Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease arthropathy
Phenotype C0019069|hemophilia
Sentences 6
PubMedID- 19943875 Background: prophylactic factor (f)viii has been shown to reduce bleeds and arthropathy in patients with severe hemophilia a.
PubMedID- 23906463 [long-term low-dose secondary prophylaxis for severe and moderate hemophilia children with arthropathy in china: a single-center observation study].
PubMedID- 24022804 arthropathy in patients with moderate hemophilia a: a systematic review of the literature.
PubMedID- 21255253 Conclusion: this randomized trial confirms the efficacy of prophylaxis in preventing bleeds and arthropathy in children with hemophilia, particularly when it is initiated early in life.
PubMedID- 21922352 To prevent joint bleedings and thus arthropathy in patients with severe hemophilia, prophylactic treatment with clotting factor concentrate is mostly indicated [13].
PubMedID- 22778972 This randomized trial confirmed the efficacy of prophylaxis in preventing bleeds and arthropathy in children with hemophilia, particularly when it is initiated early in life.

Page: 1